Samuel Bates Martin - Net Worth and Insider Trading
Samuel Bates Martin Net Worth
The estimated net worth of Samuel Bates Martin is at least $684,844 dollars as of 2025-01-12. Samuel Bates Martin is the SVP AND CFO of Celldex Therapeutics Inc and owns about 28,125 shares of Celldex Therapeutics Inc (CLDX) stock worth over $684,844. Details can be seen in Samuel Bates Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel Bates Martin has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel Bates Martin
Samuel Bates Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel Bates Martin owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Samuel Bates Martin’s form 4 insider trades.
Insider Ownership Summary of Samuel Bates Martin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2024-06-14 | SVP and CFO |
Samuel Bates Martin Latest Holdings Summary
Samuel Bates Martin currently owns a total of 1 stock. Samuel Bates Martin owns 28,125 shares of Celldex Therapeutics Inc (CLDX) as of June 14, 2024, with a value of $684,844.
Latest Holdings of Samuel Bates Martin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2024-06-14 | 28,125 | 24.35 | 684,844 |
Holding Weightings of Samuel Bates Martin
Samuel Bates Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel Bates Martin has made a total of 7 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Celldex Therapeutics Inc is the sale of 17,172 shares on June 14, 2024, which brought Samuel Bates Martin around $608,232.
Insider Trading History of Samuel Bates Martin
- 1
Samuel Bates Martin Trading Performance
GuruFocus tracks the stock performance after each of Samuel Bates Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuel Bates Martin is 301%. GuruFocus also compares Samuel Bates Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuel Bates Martin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samuel Bates Martin's insider trading performs compared to the benchmark.
Performance of Samuel Bates Martin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 315.05 | | | | | |
| Relative Return to S&P 500(%) | 316.77 | | | | | |
Samuel Bates Martin Ownership Network
Ownership Network List of Samuel Bates Martin
Ownership Network Relation of Samuel Bates Martin
Samuel Bates Martin Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Samuel Bates Martin is the SVP and CFO of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include director & President and CEO Anthony S Marucci , SVP & Chief Product Dev Officer Elizabeth Crowley , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Samuel Bates Martin made 2 insider transaction in Celldex Therapeutics Inc (CLDX) with a net sale of 52,172. Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 46,844 shares made by Richard M. Wright .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 11,500 shares, with a net purchase of 11,500 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 11,500 shares were bought by its insiders, resulting in a net sale of 342,060 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Samuel Bates Martin Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel Bates Martin. You might contact Samuel Bates Martin via mailing address: C/o Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton Nj 08827.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
